{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:49:24Z","timestamp":1787507364857,"version":"build-2736575974"},"reference-count":52,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.1167\/tvst.10.4.2","type":"journal-article","created":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T11:55:31Z","timestamp":1617278131000},"page":"2","source":"Crossref","is-referenced-by-count":26,"title":["Intraocular Pressure Reduction Effect of 0.005% Latanoprost Eye Drops in a Hyaluronic Acid-Chitosan Nanoparticle Drug Delivery System in Albino Rabbits"],"prefix":"10.1167","volume":"10","author":[{"given":"Ana Marie L.","family":"Rubenicia","sequence":"first","affiliation":[{"name":"The Graduate School, University of Santo Tomas, Manila, Philippines"},{"name":"School of Pharmacy, Centro Escolar University, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo D. P.","family":"Cubillan","sequence":"additional","affiliation":[{"name":"Philippine Eye Research Institute, PGH Compound, Ermita, Manila, Philippines"},{"name":"University of the Philippines \u2013 National Institute of Health, Ermita, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Arni D. P.","family":"Sicam","sequence":"additional","affiliation":[{"name":"Philippine Eye Research Institute, PGH Compound, Ermita, Manila, Philippines"},{"name":"University of the Philippines \u2013 National Institute of Health, Ermita, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan Patrick G.","family":"Macabeo","sequence":"additional","affiliation":[{"name":"Laboratory for Organic Reactivity, Discovery, and Synthesis (LORDS), Research Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver B.","family":"Villaflores","sequence":"additional","affiliation":[{"name":"The Graduate School, University of Santo Tomas, Manila, Philippines"},{"name":"Phytochemistry Laboratory, Research Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines"},{"name":"Department of Biochemistry, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes L.","family":"Castillo","sequence":"additional","affiliation":[{"name":"The Graduate School, University of Santo Tomas, Manila, Philippines"},{"name":"Pharmacology Laboratory, Research Center for the Natural and Applied Sciences, University of Santo Tomas, Manila, Philippines"},{"name":"Department of Pharmacy, Faculty of Pharmacy, University of Santo Tomas, Manila, Philippines"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"11","key":"bib1","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2147\/OPTH","article-title":"Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials","volume":"8","author":"Myers","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"4-5","key":"bib5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1080\/17469899.2019.1635456","article-title":"Medication adherence in patients with ocular hypertension or glaucoma","volume":"14","author":"Robin","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"issue":"4","key":"bib6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4236\/pp.2013.44054","article-title":"Comparison of efficacy and safety evaluation of latanoprost formulations with and without benzalkonium chloride","volume":"4","author":"Kasai","year":"2013","journal-title":"Pharmacol Pharm"},{"issue":"5","key":"bib7","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/eye.2011.82","article-title":"Novel drug delivery systems for glaucoma","volume":"25","author":"Lavik","year":"2011","journal-title":"Eye"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","article-title":"Nanoparticles for drug delivery to the anterior segment of the eye","volume":"122","author":"Janagam","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2147\/DDDT","article-title":"Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery","volume":"10","author":"Ahmed","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","article-title":"Chitosan-based nanostructures: A delivery platform for ocular therapeutics","volume":"62","author":"de la Fuente","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"bib12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/bjophthalmol-2015-307223","article-title":"Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis","volume":"100","author":"Kapetanakis","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"bib13","doi-asserted-by":"publisher","first-page":"5629","DOI":"10.1167\/iovs.12-9513","article-title":"Development of latanoprost-loaded biodegradable nanosheet as a new drug delivery system for glaucoma","volume":"54","author":"Kashiwagi","year":"2013","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2147\/OPTH","article-title":"Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma","volume":"10","author":"Ikeda","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"6","key":"bib15","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00417-016-3299-9","article-title":"Comparison of preservative-free latanoprost and preservative-free bimatoprost in a multicenter, randomized, investigator-masked cross-over clinical trial, the SPORT trial","volume":"254","author":"Stalmans","year":"2016","journal-title":"Graefe's Arch Clin Exp Ophthalmol"},{"issue":"1","key":"bib16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/17469899.2019.1567331","article-title":"Latanoprost, a balanced prostaglandin","volume":"14","author":"Martinez-de-la-Casa","year":"2019","journal-title":"Expert Rev Ophthalmol"},{"issue":"5","key":"bib17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3341\/kjo.2014.28.5.399","article-title":"Comparing the efficacy of latanoprost (0.005%), bimatoprost (0.03%), travoprost (0.004%), and timolol (0.5%) in the treatment of primary open angle glaucoma","volume":"28","author":"Mishra","year":"2014","journal-title":"Korean J Ophthalmol"},{"key":"bib18","first-page":"1967","article-title":"Latanoprost in the treatment of glaucoma","volume":"8","author":"Alm","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2147\/OPTH","article-title":"Ocular pharmacokinetics of bimatoprost formulated in DuraSite compared to bimatoprost 0 . 03 % ophthalmic solution in pigmented rabbit eyes","volume":"7","author":"Shafiee A","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"bib21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3390\/pharmaceutics11070321","article-title":"Penetration enhancers in ocular drug delivery","volume":"11","author":"Moiseev","year":"2019","journal-title":"Pharmaceutics"},{"issue":"6","key":"bib22","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/bjo.2010.189449","article-title":"Toxicological evaluation of preservative-containing and preservative-free topical prostaglandin analogues on a three-dimensional-reconstituted corneal epithelium system","volume":"95","author":"Liang","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024513","article-title":"Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye","volume":"6","author":"Natarajan","year":"2011","journal-title":"PLoS One"},{"key":"bib24","doi-asserted-by":"publisher","first-page":"903","DOI":"10.2147\/OPTH","article-title":"Managing adverse effects of glaucoma medications","volume":"8","author":"Inoue","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"3","key":"bib25","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.jconrel.2013.09.032","article-title":"Hyaluronic acid-coated chitosan nanoparticles: Molecular weight-dependent effects on morphology and hyaluronic acid presentation","volume":"172","author":"Almalik","year":"2013","journal-title":"J Control Release"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijbiomac.2016.04.070","article-title":"Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone","volume":"89","author":"Kalam","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"bib27","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.3390\/nano5031379","article-title":"Hyaluronic acid-chitosan nanoparticles to deliver Gd-DTPA for MR cancer imaging","volume":"5","author":"Zhang","year":"2015","journal-title":"Nanomaterials (Basel)"},{"issue":"3","key":"bib28","first-page":"955","article-title":"Preparation of chitosan - Tripolyphosphate nanoparticles for the encapsulation of polyphenols extracted from rose hips","volume":"8","author":"Stoica","year":"2013","journal-title":"Dig J Nanomater Biostructures"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.addr.2017.04.001","article-title":"Nanoparticles for drug delivery to the anterior segment of the eye","volume":"122","author":"Janagam","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"issue":"8","key":"bib30","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1007\/s11095-009-9908-0","article-title":"Chitosan\/TPP and chitosan\/TPP-hyaluronic acid nanoparticles: Systematic optimisation of the preparative process and preliminary biological evaluation","volume":"26","author":"Nasti","year":"2009","journal-title":"Pharm Res"},{"issue":"4","key":"bib31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pharmaceutics9040053","article-title":"An overview of chitosan nanoparticles and its application in non-parenteral drug delivery","volume":"9","author":"Mohammed","year":"2017","journal-title":"Pharmaceutics"},{"issue":"4","key":"bib32","first-page":"298","article-title":"Effects of latanoprost and pilocarpine combination on the intraocular pressure and pupil size of normal rabbits","volume":"12","author":"Sarchahi","year":"2011","journal-title":"Iran J Vet Res"},{"issue":"8","key":"bib33","first-page":"594","article-title":"Chitosan nanoparticles for controlled delivery of brimonidine tartrate to the ocular membrane","volume":"66","author":"Singh","year":"2011","journal-title":"Pharmazie"},{"issue":"1","key":"bib34","first-page":"1","article-title":"Ionotropic gelation: a promising cross linking technique for hydrogels","volume":"2","author":"Ahirrao","year":"2014","journal-title":"Res Rev J Pharm Nanotechnol"},{"issue":"3","key":"bib35","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/gels4030067","article-title":"Concepts for developing physical gels of chitosan and of chitosan derivatives","volume":"4","author":"Sacco","year":"2018","journal-title":"Gels"},{"issue":"7","key":"bib36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/polym12071519","article-title":"Chitosan and its derivatives for ocular delivery formulations: Recent advances and developments","volume":"12","author":"Zamboulis","year":"2020","journal-title":"Polymers (Basel)"},{"issue":"4","key":"bib37","doi-asserted-by":"publisher","first-page":"259","DOI":"10.4103\/0973-8398.143941","article-title":"Investigation of hydrogel membranes containing a combination of timolol maleate and brimonidine tartrate for ocular delivery","volume":"8","author":"Prabhu","year":"2014","journal-title":"Asian J Pharm"},{"issue":"12","key":"bib38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/md15120370","article-title":"Chitosan nanoparticles as a mucoadhesive drug delivery system for ocular administration","volume":"15","author":"Silva","year":"2017","journal-title":"Mar Drugs"},{"issue":"6","key":"bib39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.ajps.2017.04.005","article-title":"Topical delivery of acetazolamide by encapsulating in mucoadhesive nanoparticles","volume":"12","author":"Manchanda","year":"2017","journal-title":"Asian J Pharm Sci"},{"issue":"4","key":"bib40","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/10611860903450023","article-title":"Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: Development, characterization, and evaluation","volume":"18","author":"Wadhwa","year":"2010","journal-title":"J Drug Target"},{"issue":"4","key":"bib41","first-page":"775","article-title":"A circadian rhythm of aqueous flow underlies the circadian rhythm of IOP in NZW rabbits","volume":"30","author":"Smith","year":"1989","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"bib42","first-page":"235","article-title":"Hydroxyamphetamine increases intraocular pressure in rabbits","volume":"119","author":"Okada","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"bib43","first-page":"244","article-title":"Measurement of intraocular pressure by telemetry in conscious, unrestrained rabbits","volume":"18","author":"Percicot","year":"1999","journal-title":"J Toxicol - Cutan Ocul Toxicol"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.2147\/OPTH","article-title":"Ocular pharmacokinetics of bimatoprost formulated in Durasite compared to bimatoprost 0.03% ophthalmic solution in pigmented rabbit eyes","volume":"7","author":"Shafiee","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"Part A","key":"bib45","doi-asserted-by":"publisher","first-page":"101575","DOI":"10.1016\/j.jddst.2020.101575","article-title":"In situ gel containing Bimatoprost solid lipid nanoparticles for ocular delivery: In-vitro and ex-vivo evaluation","volume":"56","author":"Wadetwar","year":"2020","journal-title":"J Drug Deliv Sci Technol"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"102260","DOI":"10.1016\/j.nano.2020.102260","article-title":"Self-assembled DNA nanoparticles loaded with travoprost for glaucoma-treatment","volume":"29","author":"Schnichels","year":"2020","journal-title":"Nanomedicine"},{"issue":"1","key":"bib47","first-page":"1","article-title":"Development and in vitro\/in vivo evaluation of liposomal gels for the sustained ocular delivery of latanoprost","volume":"6","author":"Soliman","year":"2015","journal-title":"J Clin Exp Ophthalmol"},{"issue":"January","key":"bib48","first-page":"123","article-title":"Nanomedicine for glaucoma: Liposomes provide sustained release of latanoprost in the eye","volume":"7","author":"Natarajan","year":"2012","journal-title":"Int J Nanomedicine"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.ijbiomac.2016.05.016","article-title":"The potential application of hyaluronic acid coated chitosan nanoparticles in ocular delivery of dexamethasone","volume":"89","author":"Kalam","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"5","key":"bib50","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s41433-018-0042-2","article-title":"Normal tension glaucoma: Review of current understanding and mechanisms of the pathogenesis","volume":"32","author":"Killer","year":"2018","journal-title":"Eye"},{"issue":"4","key":"bib51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","author":"Anderson","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"bib52","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1097\/00132578-200310000-00007","article-title":"Factors for glaucoma progression and the effect of treatment","volume":"4","author":"Leske","year":"2003","journal-title":"Evidence-Based Eye Care"},{"key":"bib2","volume-title":"Pharmacotherapy: A Pathophysiologic Approach","author":"Dipiro","year":"2014","edition":"9th ed."},{"key":"bib3","first-page":"41","volume-title":"\u00a9 2016 by the American Academy of Ophthalmology","author":"Emptage","year":"2016"},{"key":"bib9","volume-title":"Martin's Physical Pharmacy and Pharmaceutical Sciences","author":"Sinko","year":"2016","edition":"7th ed."},{"key":"bib19","volume-title":"Pharmaceutical Preformulation and Formulation","author":"Gibson","year":"2009","edition":"2nd ed."}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T11:55:46Z","timestamp":1617278146000},"score":1,"resource":{"primary":{"URL":"https:\/\/tvst.arvojournals.org\/article.aspx?articleid=2772438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.10.4.2","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}